Evidence map›Paper›PMID 42305005›Full record

ReviewZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics2026

[Guillain-Barré syndrome following allogeneic hematopoietic stem cell transplantation in a pediatric patient: a case report and literature review].

Jia-Yi Lyu, Xiao-Hui Zhou, Chun-Jing Wang, Chun-Lan Yang, Ming-Jing Luo, Si-Xi Liu

Abstract readCase ReportsReviewEnglish Abstract
In one paragraph

Review in Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jia-Yi LyuDepartment of Hematology and Oncology, Shenzhen Children's Hospital, Shenzhen 518000, China.
Xiao-Hui ZhouDepartment of Hematology and Oncology, Shenzhen Children's Hospital, Shenzhen 518000, China.
Chun-Jing WangDepartment of Hematology and Oncology, Shenzhen Children's Hospital, Shenzhen 518000, China.
Chun-Lan YangDepartment of Hematology and Oncology, Shenzhen Children's Hospital, Shenzhen 518000, China.
Ming-Jing LuoDepartment of Hematology and Oncology, Shenzhen Children's Hospital, Shenzhen 518000, China.
Si-Xi LiuDepartment of Hematology and Oncology, Shenzhen Children's Hospital, Shenzhen 518000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 10-year-old girl diagnosed with hyper-IgE syndrome for more than six years developed dizziness and symmetrical progressive limb weakness one week prior to hospital admission, occurring 4 months after allogeneic hematopoietic stem cell transplantation. On post-transplant day 121, dizziness and progressive, symmetric limb weakness appeared. Cerebrospinal fluid analysis revealed albuminocytologic dissociation. Electromyography confirmed multiple peripheral nerve lesions, consistent with the diagnosis of Guillain-Barré syndrome. Intravenous immunoglobulin therapy showed limited efficacy, whereas corticosteroid therapy produced significant clinical improvement. Neurological symptoms fully resolved after treatment; however, severe chronic graft-versus-host disease occurred subsequently. Based on this case, related literature was reviewed and summarized to provide references for early diagnosis, mechanistic investigation, and treatment options.

Indexed as

Guillain-Barre SyndromeHematopoietic Stem Cell TransplantationChildFemaleGraft vs Host DiseaseHumansTransplantation, HomologousAllogeneic hematopoietic stem cell transplantationChildGraft-versus-host diseaseGuillain-Barré syndrome

Identifiers

PMID42305005
PMCPMC13273527

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.